Lyell Immunopharma

LYEL

NASDAQHealth Care

Income Statement

Total Revenue$61K

Gross Profit$61K

Operating Income$-358.76M

EBITDA$-323.36M

EBIT$-342.99M

Pre-tax Income$-331.4M

Net Income$-342.99M

Cash Equivalent$116.88M

Total Debt$52.73M

Book Value$520.79M

Book Value Per Share1.99

Return on Equity (ROE)-89.60%

Return on Assets (ROA)-69.88%

Return on Invested Capital (ROI)-89.60%

Net Profit Margin-562285.25%

Current Ratio7.06

Quick Ratio6.89

Long-Term Debt / Equitynull